ClinConnect ClinConnect Logo
Search / Trial NCT07005960

The Application of Art Therapy to Patients Undergoing Hemodialysis Treatment

Launched by EMİNE İNAL · May 28, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Art Therapy Art Therapy Applied To Hemodialysis Patients Anxiety And Psychological Well Being

ClinConnect Summary

This clinical trial is looking into how art therapy can help patients with chronic kidney disease who are receiving hemodialysis. Many of these patients deal with anxiety and depression, which can make their treatment experience more difficult. Art therapy is a creative approach that allows patients to express themselves and can help reduce anxiety, boost self-confidence, and promote relaxation, leading to an overall better quality of life.

To participate in this study, individuals need to be between 18 and 65 years old and have been undergoing hemodialysis for at least six months. They should also be able to communicate well and not have any infections or sensory impairments like vision or hearing loss. If you join the trial, you can expect to engage in art therapy sessions, which will be evaluated to see how they affect your anxiety and resilience. This study is still in the planning stages and has not started recruiting participants yet.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Undergoing hemodialysis for at least 6 months,
  • Willing to participate in the study,
  • Aged between 18 and 65 years,
  • No communication disorders,
  • No infectious diseases.
  • Exclusion Criteria:
  • Sensory impairments (vision or hearing loss),
  • Not willing to participate in the study,
  • Having an infectious disease.
  • Independent and Dependent Variables:
  • Independent Variable: Art therapy. Dependent Variables: Scores from the Brief Resilience Scale and State-Trait Anxiety Inventory (STAI 1-STAI 2).
  • Control Variables: Participants' sociodemographic characteristics.
  • -

About Emi̇ne İnal

Emine İnal is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on improving patient outcomes, she leads initiatives that emphasize rigorous scientific methodology and ethical standards. Emine's expertise spans various therapeutic areas, ensuring that clinical trials are designed and executed with the highest level of precision and compliance. By fostering collaboration among researchers, healthcare professionals, and regulatory bodies, she plays a pivotal role in bridging the gap between groundbreaking research and real-world applications, ultimately contributing to the enhancement of healthcare solutions.

Locations

Patients applied

0 patients applied

Trial Officials

Sibel Olca POLAT

Study Director

sibelolca@aydın.edu.tr

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported